Position in VSTM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$53,751
New position
Shares Held
14,071
first reported quarter
Ownership
0.016%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#108
of 158 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 30%
None 70%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Regal Investment Advisors LLC holds $10,476,569 across 7 Biotechnology names. VSTM ranks #7 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
103,861 | $5,823,486 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,238 | $1,608,411 | |
| 3 | KRYS |
Krystal Biotech, Inc.
|
3,913 | $1,454,344 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,432 | $732,104 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
9,366 | $535,922 | |
| 6 | DFTX |
Definium Therapeutics, Inc.
|
5,709 | $268,551 | |
| 7 | VSTM |
Verastem, Inc.
This page
|
14,071 | $53,751 |
All Filings in VSTM
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $53,751 | 14,071 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||